John C Dickson
Overview
Explore the profile of John C Dickson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1421
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Murray A, Scuffham J, Dickson J, Memmott M
Nucl Med Commun
. 2024 Oct;
46(1):106-108.
PMID: 39410902
Introduction: The use of in-house developed software as a medical device (IHD-SaMD) is core to many nuclear medicine (NM) services in the UK, including applications in nonimaging studies and image...
2.
De Schepper S, Gnanasegaran G, De Vos W, Van de Casteele E, Dickson J, Van den Wyngaert T
EJNMMI Phys
. 2024 Aug;
11(1):74.
PMID: 39177939
Background: Unilateral condylar hyperplasia (UCH) of the mandible is a rare condition characterized by asymmetric growth of the mandibular condyles. Bone scintigraphy with SPECT(/CT) is commonly used to diagnose UCH...
3.
Hastings A, Cullinane P, Wrigley S, Revesz T, Morris H, Dickson J, et al.
Neurology
. 2024 May;
102(11):e209453.
PMID: 38759132
Background And Objectives: Degeneration of the presynaptic nigrostriatal dopaminergic system is one of the main biological features of Parkinson disease (PD), multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and...
4.
Scuffham J, Dickson J, Murray A, Flux G
Nucl Med Commun
. 2024 May;
45(6):541-545.
PMID: 38716744
No abstract available.
5.
Murray-Smith H, Barker S, Barkhof F, Barnes J, Brown T, Captur G, et al.
BMC Neurol
. 2024 Jan;
24(1):40.
PMID: 38263061
Background: Although age is the biggest known risk factor for dementia, there remains uncertainty about other factors over the life course that contribute to a person's risk for cognitive decline...
6.
Keuss S, Coath W, Cash D, Barnes J, Nicholas J, Lane C, et al.
J Neurol Neurosurg Psychiatry
. 2024 Jan;
95(8):748-752.
PMID: 38199813
Background: Consistent patterns of reduced cortical thickness have been identified in early Alzheimer's disease (AD). However, the pathological factors that influence rates of cortical thinning within these AD signature regions...
7.
Michopoulou S, Dickson J, Gardner G, Gee T, Fenwick A, Melhuish T, et al.
Nucl Med Commun
. 2023 Jul;
44(10):834-842.
PMID: 37464866
Objectives: With disease-modifying therapies in development for neurological disorders, quantitative brain imaging techniques become increasingly relevant for objective early diagnosis and assessment of response to treatment. The aim of this...
8.
Dickson J, Armstrong I, Minguez Gabina P, Denis-Bacelar A, Krizsan A, Gear J, et al.
Eur J Nucl Med Mol Imaging
. 2022 Dec;
50(4):980-995.
PMID: 36469107
Purpose: Quantitative SPECT-CT is a modality of growing importance with initial developments in post radionuclide therapy dosimetry, and more recent expansion into bone, cardiac and brain imaging together with the...
9.
Keuss S, Coath W, Nicholas J, Poole T, Barnes J, Cash D, et al.
Neurology
. 2022 Apr;
99(2):e129-e141.
PMID: 35410910
Background And Objectives: The goals of this work were to quantify the independent and interactive associations of β-amyloid (Aβ) and white matter hyperintensity volume (WMHV), a marker of presumed cerebrovascular...
10.
De Schepper S, Gnanasegaran G, Dickson J, Van den Wyngaert T
Diagnostics (Basel)
. 2021 Dec;
11(12).
PMID: 34943570
The application of absolute quantification in SPECT/CT has seen increased interest in the context of radionuclide therapies where patient-specific dosimetry is a requirement within the European Union (EU) legislation. However,...